This article is more than 5 years old. Information may no longer be current.

TearLab, AMO Canada enter agreement to co-market dry eye products

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

TearLab Corporation and AMO Canada, a subsidiary of Abbott Medical Optics, have entered into a cooperative marketing agreement, the companies announced in a press release.

Under the agreement, AMO Canada will sell the TearLab Osmolarity System and TearLab will promote AMO Canada's dry eye products, including Blink Moisturizing Eye Drops. Financial terms of the agreement were not disclosed, according to the release.

The TearLab Osmolarity System measures the osmolarity of tears to help diagnosis dry eye disease. The lab-on-a-chip design requires only 50 nL of liquid and displays results in less than 30 seconds, the release said.